The Food and Drug Administration (FDA) Commissioner Marty Makary has celebrated his one-year tenure as head of the country's drug regulatory authority, stating that he helped bring "healing" to the agency following cuts by the Department of Government Efficiency (DOGE). Makary highlighted the changes at the FDA, including increased new medication approvals, shorter review times, and the adoption of artificial intelligence tools. He also mentioned that he convinced staff considering retirement to stay on and eliminated plans for major reorganizations within the agency.